Publicaciones en las que colabora con Javier Pemán García (36)

2022

  1. Impact of Aspergillus spp. isolation in the first 24 hours of admission in critically ill patients with severe influenza virus pneumonia

    Medicina Intensiva

  2. Impact of Aspergillus spp. isolation in the first 24 hours of admission in critically ill patients with severe influenza virus pneumonia

    Medicina intensiva, Vol. 46, Núm. 8, pp. 426-435

  3. In Vitro Antifungal Activity of Ibrexafungerp (SCY-078) Against Contemporary Blood Isolates From Medically Relevant Species of Candida: A European Study

    Frontiers in Cellular and Infection Microbiology, Vol. 12

2021

  1. In vitro pharmacokinetic/pharmacodynamic modelling and simulation of amphotericin b against candida auris

    Pharmaceutics, Vol. 13, Núm. 11

  2. Liposomal amphotericin B: thirty years of a highly effective therapy for the treatment of invasive mycoses

    Revista Iberoamericana de Micologia, Vol. 38, Núm. 2, pp. 39-41

2020

  1. Fungal co-infection in COVID-19 patients: Should we be concerned?

    Revista Iberoamericana de Micologia

  2. Utility of two PCR-RFLP-based techniques for identification of Candida parapsilosis complex blood isolates

    Mycoses, Vol. 63, Núm. 5, pp. 461-470

2019

  1. Method-dependent epidemiological cutoff values for detection of triazole resistance in Candida and Aspergillus species for the Sensititre Yeastone colorimetric broth and etest agar diffusion methods

    Antimicrobial Agents and Chemotherapy, Vol. 63, Núm. 1

2018

  1. Developing collaborative works for faster progress on fungal respiratory infections in cystic fibrosis

    Medical Mycology, Vol. 56, pp. S42-S59

2016

  1. Aspectos actuales de las enfermedades invasoras causadas por Candida y otros hongos levaduriformes

    Revista Iberoamericana de Micologia

  2. Enfermedad fúngica invasiva por Candida y otros hongos levaduriformes

    Revista Iberoamericana de Micologia, Vol. 33, Núm. 3, pp. 131-132

2015

  1. Multicenter Study of Epidemiological Cutoff Values and Detection of Resistance in Candida spp. to Anidulafungin, Caspofungin, and Micafungin Using the Sensititre YeastOne Colorimetric Method

    Antimicrobial Agents and Chemotherapy, Vol. 59, Núm. 11, pp. 6725-6732

2014

  1. Invasive infection diseases by filamentous fungi

    Revista Iberoamericana de Micologia, Vol. 31, Núm. 4, pp. 211-212

  2. State of the Art in the Laboratory Methods for the Diagnosis of Invasive Fungal Diseases

    Microbiology for Surgical Infections: Diagnosis, Prognosis and Treatment (Elsevier Inc.), pp. 281-297

  3. State of the art in invasive diseases by filamentous fungi

    Revista Iberoamericana de Micologia, Vol. 31, Núm. 4, pp. 213-218

2012

  1. Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey

    Journal of Antimicrobial Chemotherapy, Vol. 67, Núm. 5, pp. 1181-1187

2011

  1. Clinical factors associated with a Candida albicans Germ Tube Antibody positive test in Intensive Care Unit patients

    BMC Infectious Diseases, Vol. 11

  2. Guidelines for the treatment of invasive fungal disease by Aspergillus spp. and other fungi issued by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2011 Update

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. 6, pp. 435-454

  3. Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemia

    Antimicrobial Agents and Chemotherapy, Vol. 55, Núm. 12, pp. 5590-5596

  4. Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC) guidelines for the diagnosis of invasive fungal infections. 2010 Update

    Enfermedades Infecciosas y Microbiologia Clinica